Skip to search formSkip to main contentSkip to account menu

PNU 166196

Known as: PNU-166196, PNU166196 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
In this review article we have reported a series of hybrid compounds characterized by the presence of a alpha-halogenocryloyl… 
2007
2007
B77 PNU-166196 is a DNA minor groove binder in Phase II clinical development. Data suggest that PNU-166196 is activated by… 
2003
2003
PURPOSE Brostallicin (PNU-166196) is a cytotoxic agent that binds to the minor groove of DNA with significant antitumor activity… 
2003
2003
PURPOSE Brostallicin (PNU-166196) is a alpha-bromoacrylic DNA minor groove binder, currently in clinical evaluation. This drug… 
2003
2003
Purpose: Brostallicin (PNU-166196) is a cytotoxic agent that binds to the minor groove of DNA with significant antitumor activity…